Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 21,502	$ 16,557
Restricted cash	300	0
Accounts receivable, net of allowance for credit losses of $592 and $3,322, respectively	17,153	13,973
Inventory	10,597	6,493
Prepaid expenses and other current assets	2,729	2,921
Total current assets	52,281	39,944
Property and equipment, net	152	377
Right of use assets, net	67	937
Intangible assets, net	870	2,210
Other assets	2,760	655
Total assets	56,130	44,123
Current liabilities:
Accounts payable	11,518	13,679
Accrued and other expenses	12,430	15,051
Current portion of deferred revenues	1,401	1,166
Line of credit	9,875	9,250
Current portion of long-term and other debt	466	5,944
Total current liabilities	35,690	45,090
Long-term debt, net	4,585	0
Common stock warrant liabilities	25,102	27,781
Other long-term liabilities	143	928
Total liabilities	65,520	73,799
Commitments and Contingencies
Mezzanine equity:
Mezzanine equity	12,069	7,855
Stockholders’ deficit:
Common stock, $0.0001 par value, 107,142,857 shares authorized as of September 30, 2024 and December 31, 2023; 15,393,881 and 8,797,456 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively	2	1
Additional paid-in capital	237,682	218,127
Accumulated deficit	(259,143)	(255,659)
Total stockholders’ deficit	(21,459)	(37,531)
Total liabilities, mezzanine equity, and stockholders’ deficit	56,130	44,123
Series A Convertible Preferred Stock
Mezzanine equity:
Mezzanine equity	4,652	7,855
Series B Convertible Preferred Stock
Mezzanine equity:
Mezzanine equity	3,104	0
Redeemable Common Stock
Mezzanine equity:
Mezzanine equity	$ 4,313	$ 0